Purchase Order VA664D10012

<p>The National Institute of Child Health and Human Development issued a purchase order to Cyagen US Inc. for $97,577 on September 14, 2020, for turboknockout mouse gene targeting services. Work is performed in Santa Clara, California. The order is firm fixed price with an ultimate completion date of June 22, 2021. The underlying solicitation was posted August 12, 2020, with a due date of August 21, 2020.</p>

This federal contract award to the University of California, Davis (UC Davis) is for the microinjection of the 1700013H16Rik gene into embryonic stem cells to create specific knockout mice for the Knockout Mouse Project (KOMP). The $10,768 firm fixed-price purchase order was awarded by the Uniformed Services University of the Health Sciences, a defense agency, with an ultimate completion date of August 12, 2011. The contract does not have a small business set-aside designation. As a major public...

<p>The National Institutes of Health awarded a purchase order to Texas A&amp;M University-Corpus Christi for an agreement for mutant mouse with a ceiling value of $17,500.00, dated April 30, 2009. Work is performed in Corpus Christi, Texas, with an ultimate completion date of May 29, 2009.</p>

<p>The U.S. Department of Agriculture awarded a purchase order to Cyagen Biomodels LLC valued at $197,805 on August 18, 2025, to develop customized, gene-targeted mouse lines supporting the study of prion origin, transmission, and strain diversity in cervids and livestock. Work will be performed in Santa Clara, California under a firm fixed-price structure with completion targeted for February 26, 2027. The purchase order carries no small business set-aside.</p>

<p>The Office of Logistics and Acquisition Operations awarded a purchase order to the Board of Regents of the University of Nebraska valued at $15,002 for generation of a CRE-ERT2 knock-in mouse model for OCM gene using the EASI-CRISPR approach, with award date of September 8, 2018 and ultimate completion date of September 9, 2019. Place of performance is Bethesda, Maryland. The purchase order is firm fixed price with no set-aside applied.</p>

This $11,337.01 firm-fixed-price purchase order was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to the University of California, Davis (UC Davis) to provide a conditional myosin VA mouse model. The purpose is to investigate the biological function of myosin VA, which is a motor protein involved in various cellular processes. This award is not designated as a small business set-aside. UC Davis is a...

<p>The National Institutes of Health, through the Office of Logistics and Acquisition Operations, awarded a purchase order to Genecopoeia, Inc. for $11,000.00 on August 22, 2014, for generation of a transgenic mouse line containing 3'&amp;5'-terminal EGFP tag. Genecopoeia is a minority-owned, Asian-Pacific American-owned biotechnology firm. Place of performance is Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of January 5, 2019.</p>

This is a $19,206 firm-fixed price purchase order awarded by the Office of Logistics and Acquisition Operations, part of the National Institutes of Health (NIH), to the Board of Regents of the University of Nebraska, doing business as the University of Nebraska Medical Center (UNMC). The contract is for UNMC to generate two CRISPR-EASI transgenic mice for the National Institute on Deafness and Other Communication Disorders (NIDCD). UNMC was selected on a sole-source basis as the only facility...

This is a $18,243.50 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Cyagen Biomodels LLC, a for-profit biotechnology company in Santa Clara, California. The contract is for laboratory research to generate a mouse YWHAE (N terminal-EGFP) knockin project on a C57BL/6J genetic background. This specialized genetic engineering service supports advanced scientific investigations across multiple...

This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the development of a conditional knockout mouse line to support NICHD's research. The total ceiling value of the contract is $14,380.00 with a completion date of January 5, 2024. There is no set-aside...